Abstract. Even though adrenergic nerve terminals between and around thyroid follicles and catecholamine stimulation of thyroid adenylate cyclase have been reported, there is no uniform concept on catecholamine interaction with thyrotrophin (TSH) receptors. There-fore, the effect of catecholamines on TSH-stimulated cyclic AMP (cAMP) accumulation in human follicular thyroid cells has been investigated, to thus eliminating the extrathyroidal actions of catecholamines. Epinephrine, norepinephrine and isoproterenol appeared to be rapid and potent stimulators of intracellular cAMP accumulation, the half maximum increase doses being 4 \m=x\10\m=-\7m, 1 \m=x\10\m=-\5m and5 \m=x\10\m=-\7m, respectively. While propranolol (1 \ m=x\10\m=-\5m) prevented the stimulatory effect of catecholamines and failed to inhibit the effect of bovine TSH, phentolamine (1 \m=x\10\m=-\5m) enhanced the potency of norepinephrine and bovine TSH, leaving that of epinephrine unchanged. The effects of epinephrine (2 \m=x\ 10\m=-\8m) and isoproterenol (2 \m=x\ 10\m=-\8m) were additive to that of bovine TSH (0.5 mU/ml), but the effect of simultaneous stimulation with norepinephrine (5 \m=x\10\m=-\7m) and bovine TSH (0.5 mU/ml) was lower than expected. Prenalterol The results indicate the existence of ß-adrenergic receptors in human thyroid cells and suggest that their role is independent of the action of TSH. In addition a-adrenergic receptors seem to be in¬ volved in the counter-regulation of TSH action.
cyclic AMP (cAMP) accumulation in human follicular thyroid cells has been investigated, to thus eliminating the extrathyroidal actions of catecholamines. Epinephrine, norepinephrine and isoproterenol appeared to be rapid and potent stimulators of intracellular cAMP accumulation, the half maximum increase doses being 4 \m=x\10\m=-\7m, 1 \m=x\10\m=-\5m and5 \m=x\10\m=-\7m, respectively. While propranolol (1 \ m=x\10\m=-\5m) prevented the stimulatory effect of catecholamines and failed to inhibit the effect of bovine TSH, phentolamine (1 \m=x\10\m=-\5m) enhanced the potency of norepinephrine and bovine TSH, leaving that of epinephrine unchanged. The effects of epinephrine (2 \m=x\ 10\m=-\8m) and isoproterenol (2 \m=x\ 10\m=-\8m) were additive to that of bovine TSH (0.5 mU/ml), but the effect of simultaneous stimulation with norepinephrine (5 \m=x\10\m=-\7m) and bovine TSH (0.5 mU/ml) was lower than expected. Prenalterol (Maayan & Ingbar 1970) , bovine thy¬ roid plasma membranes (Marshall et al. 1975 ) and slices (Spaulding & Burrow 1975) (Brown et al. 1971 ) and corrected by the DNA content, measured by a fluorometric method (Kissane & Robins 1958) adapted by us for use with cell culture (Toccafondi et al. 1980 ).
Drugs
Bovine TSH (Ambinon, Organon, Oss, Holland) was purified by gel filtration on Ultrogel AcA 44 (LKB, Sweden), collecting the 28 000 mw peak with the maximal activity in stimulating cAMP accumulation in thyroid culture cells (Toccafondi et al. 1980 ) and a specific activity of 8 IU/mg calculated in comparison with the International Standard of Biological Activity (NIBSC 53/11 The effect of different doses of bovine TSH on cAMP intracellular levels was studied and a dosedependent increase in cAMP levels was found after 30 min incubation from a dose of 4.4 x 10~10 m, while the maximum was reached with a dose of 1.1 x 10"8M( Fig. 1) .
Effects of adrenergk blockers on catecholamine-and TSH-induced cAMP accumulation
To investigate whether the effect of catecholamines on cAMP accumulation in human thyroid cells could be mediated through a-adrenergic recep¬ tors, the effect of a 10 min preincubation with phentolamine (an a-blocking agent) on the influ¬ ence of E and NE was studied. As shown in Table 1 , PhA (1 x 10"5 m) enhanced the potency of NE (1 X 10-5 M) (+140%), leaving the response to E (1 x 10"7M) unchanged, while no effect was elicited by PhA (1 x 10-5 m) alone. The effect of preincu¬ bation with PhA was also studied on TSH-induced cAMP accumulation, to verify whether the effect of TSH could involve an a-adrenergic mechanism. PhA (1 x 10"s M) significantly increased (+100%) the potency of a submaximal dose of bovine TSH (0.5 mU/ml) ( Table 1 ). (Table 2) . Pro (1 x 10"5M) completely inhibited the stimula¬ tory effect of E ( 1 x 10"7M), IPNE (I x 10"6M)and NE (1 X 10-5 M), while no effect was elicited on cAMP by Pro alone. On the contrary, Pro ( 1 x 10"5 m) failed to inhibit the effect of a submaxi¬ mal dose of bovine TSH (0.5 mU/ml) ( Table 2) . Effect of simultaneous stimulation with bovine TSH (0.5 mU/ml) and epinephrine (2 x 10"8m; A) norepine¬ phrine (5 X 10-7 M; B) and isoproterenol (2 X (Marshall et al. 1975) , organ fragments (Gilman & Rail 1968; Sato et al. 1976) or dispersed cells (Maayan & Ingbar 1970 Melander (1970) and 'in vitro' by Marshall et al. (1975) (Davies et al. 1977; Marshalletal. 1975; Taninietal. 1978 ).
The stimulatory effect of terbutaline, a ß2-adrenergic agonist, the lack of effect of prenalterol, a ßt-adrenergic agonist, and the ineffectiveness of metoprolol, a ßj-adrenergic blocker, imply that the ß-adrenergic receptors in human thyroid follicular cells may be classified as ß2 receptors. These data in humans agree with results from animal studies (Melander et al. 1975 ).
Phentolamine increased the effect of NE. These data disagree with those of others (Sato et (1974) in studies with bovine plasma membranes and by Yamashita et al. (1979) in dog thyroid slices.
In conclusion, the present data provide evidence for the existence of ß-adrenergic receptors in hu¬ man thyroid follicular cells, apparently different from TSH receptors. In addition, the existence of a-adrenergic receptors involved in TSH action counter-regulation may be postulated.
